Next Article in Journal
Clinical Toxicities of Histone Deacetylase Inhibitors
Next Article in Special Issue
Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis
Previous Article in Journal
Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy
Previous Article in Special Issue
Cannabinoids and Dementia: A Review of Clinical and Preclinical Data
Article Menu

Export Article

Open AccessReview
Pharmaceuticals 2010, 3(8), 2733-2750;

Dendritic Cell Regulation by Cannabinoid-Based Drugs

Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, 141 86, Stockholm, Sweden
Author to whom correspondence should be addressed.
Received: 2 July 2010 / Revised: 11 August 2010 / Accepted: 20 August 2010 / Published: 23 August 2010
(This article belongs to the Special Issue Cannabinoids)
Full-Text   |   PDF [318 KB, uploaded 23 August 2010]   |  


Cannabinoid pharmacology has made important advances in recent years after the cannabinoid system was discovered. Studies in experimental models and in humans have produced promising results using cannabinoid-based drugs for the treatment of obesity and cancer, as well as neuroinflammatory and chronic inflammatory diseases. Moreover, as we discuss here, additional studies also indicates that these drugs have immunosuppressive and anti-inflammatory properties including modulation of immune cell function. Thus, manipulation of the endocannabinoid system in vivo may provide novel therapeutic strategies against inflammatory disorders. At least two types of cannabinoid receptors, cannabinoid 1 and cannabinoid 2 receptors are expressed on immune cells such as dendritic cells (DC). Dendritic cells are recognized for their critical role in initiating and maintaining immune responses. Therefore, DC are potential targets for cannabinoid-mediated modulation. Here, we review the effects of cannabinoids on DC and provide some perspective concerning the therapeutic potential of cannabinoids for the treatment of human diseases involving aberrant inflammatory processes. View Full-Text
Keywords: Cannabinoids; dendritic cells; inflammation; immunomodulation; KV-channels Cannabinoids; dendritic cells; inflammation; immunomodulation; KV-channels

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Svensson, M.; Chen, P.; Hammarfjord, O. Dendritic Cell Regulation by Cannabinoid-Based Drugs. Pharmaceuticals 2010, 3, 2733-2750.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top